Titomic Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TITMF research report →
Price Chart
About the company
Titomic Ltd. engages in the manufacture and provision of technology solutions for metal additive manufacturing, metal coatings, and repairs using Titomic Kinetic Fusion cold spray technology. It operates through the following segments: Australia, USA, and Netherlands.
- CEO
- James S. Simpson
- IPO
- 2020
- Employees
- 83
- HQ
- Huntsville, AL, US
Get TickerSpark's AI analysis on TITMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $144.68M
- P/E
- -6.96
- Fwd P/E
- 36.11
- PEG
- 0.06
- P/S
- 25.16
- P/B
- 5.18
- EV/EBITDA
- -7.30
- Div Yield
- 0.00%
- Gross Margin
- -32.39%
- Op Margin
- -317.21%
- Net Margin
- -338.69%
- ROE
- -74.68%
- ROIC
- -51.24%
Latest fiscal year · YoY change
- Revenue
- $10.54M+11.8%
- Gross Profit
- $-3,414,650-402.4%
- Op Income
- $-33,438,384
- Net Income
- $-35,702,598-79.5%
- EPS
- $-0.02-44.5%
- OCF Growth
- -101.9%
- FCF Growth
- -59.9%
- 52W High
- $0.30
- 52W Low
- $0.07
- 50D MA
- $0.13
- 200D MA
- $0.17
- Beta
- 0.59
- RSI (14)
- 11
- Avg Volume
- 916
No earnings-call transcripts are available for TITMF yet.
- Free Float
- 72.8%
- Shares Outstanding
- 1.61B
- Float Shares
- 1.17B
Our TITMF coverage
Recent articles, reports, and earnings notes.
No research on TITMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TITMF report →Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI
proactiveinvestors.com · Mar 27
Titomic lands $1.7 million Royal NLR order for cold spray systems
proactiveinvestors.com · Mar 27
Acadia Pharmaceuticals upgraded on improve risk-reward profile following pullback
proactiveinvestors.com · Mar 25
Microsoft price target lowered on M365, Copilot questions
proactiveinvestors.com · Mar 25
Atlassian to reduce headcount by 10% as it restructures around AI
proactiveinvestors.com · Mar 12
Titomic plans US redomicile as defence market focus grows
proactiveinvestors.com · Mar 12
Tap Global shares rise 6% as directors lock in 63% of shares for three years
proactiveinvestors.com · Mar 12
Titomic Limited (TITMF) Shareholder/Analyst Call Transcript
seekingalpha.com · Nov 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.